Log In
Print
BCIQ
Print
Print this Print this
 

margetuximab (MGAH22)

  Manage Alerts
Collapse Summary General Information
Company MacroGenics Inc.
DescriptionFc optimized mAb against HER2
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today